These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8076906)

  • 21. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carboxy-terminal propeptide of human type I collagen and pyridinium cross-links as markers of bone growth in infants 1 to 18 months of age.
    Lieuw-A-Fa M; Sierra RI; Specker BL
    J Bone Miner Res; 1995 Jun; 10(6):849-53. PubMed ID: 7572307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover.
    Sartorio A; Conti A; Monzani M; Morabito F; Faglia G
    J Endocrinol Invest; 1993 Dec; 16(11):893-8. PubMed ID: 8144866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy.
    Conti A; Sartorio A; Ferrero S; Ferrario S; Ambrosi B
    J Endocrinol Invest; 1996 Feb; 19(2):127-30. PubMed ID: 8778165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal.
    Parkinson C; Kassem M; Heickendorff L; Flyvbjerg A; Trainer PJ
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5650-5. PubMed ID: 14671148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome.
    Klinger B; Jensen LT; Silbergeld A; Laron Z
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):423-9. PubMed ID: 8959080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG).
    Abildgaard N; Bentzen SM; Nielsen JL; Heickendorff L
    Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis.
    Kröger H; Risteli J; Risteli L; Penttilä I; Alhava E
    Ann Rheum Dis; 1993 May; 52(5):338-42. PubMed ID: 8323381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a growth hormone receptor antagonist on bone markers in acromegaly.
    Fairfield WP; Sesmilo G; Katznelson L; Pulaski K; Freda PU; Stavrou S; Kleinberg D; Klibanski A
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):385-90. PubMed ID: 12201832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum bone Gla protein and carboxyterminal cross-linked telopeptide of type I collagen in patients with Cushing's syndrome.
    Sartorio A; Conti A; Ferrario S; Passini E; Re T; Ambrosi B
    Postgrad Med J; 1996 Jul; 72(849):419-22. PubMed ID: 8935602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 12 months rhGH treatment on bone and collagen turnover in children with constitutional growth delay.
    Sartorio A; Conti A; Ferrero S; Saraifoger S; Resnik M; Baroncelli GI
    J Pediatr Endocrinol Metab; 1999; 12(6):833-8. PubMed ID: 10614540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collagen metabolism in obesity: the effect of weight loss.
    Rasmussen MH; Jensen LT; Andersen T; Breum L; Hilsted J
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):659-63. PubMed ID: 8574277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma and tissue levels of collagen types I and III markers in patients with abdominal aortic aneurysms.
    Treska V; Topolcan O
    Int Angiol; 2000 Mar; 19(1):64-8. PubMed ID: 10853688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical bone markers compared with bone density measurement by dual energy X-ray absorptiometry.
    Lotz J; Steeger D; Hafner G; Ehrenthal W; Heine J; Prellwitz W
    Calcif Tissue Int; 1995 Oct; 57(4):253-7. PubMed ID: 8673861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elite volunteer athletes of different sport disciplines may have elevated baseline GH levels divorced from unaltered levels of both IGF-I and GH-dependent bone and collagen markers: a study on-the-field.
    Sartorio A; Marazzi N; Agosti F; Faglia G; Corradini C; De Palo E; Cella S; Rigamonti A; Muller EE
    J Endocrinol Invest; 2004 May; 27(5):410-5. PubMed ID: 15279071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum type III procollagen propeptide levels in acromegalic patients.
    Verde GG; Santi I; Chiodini P; Cozzi R; Dallabonzana D; Oppizzi G; Liuzzi A
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1406-10. PubMed ID: 2878008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults.
    Johansen JS; Pedersen SA; Jørgensen JO; Riis BJ; Christiansen C; Christiansen JS; Skakkebaek NE
    J Clin Endocrinol Metab; 1990 Apr; 70(4):916-9. PubMed ID: 2180981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis.
    Ueland T; Bollerslev J; Godang K; Müller F; Frøland SS; Aukrust P
    Eur J Endocrinol; 2001 Dec; 145(6):685-90. PubMed ID: 11720891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of octreotide on markers of bone metabolism in acromegaly: evidence of increased serum parathormone concentrations.
    Legovini P; De Menis E; Breda F; Billeci D; Carteri A; Pavan P; Conte N
    J Endocrinol Invest; 1997 Sep; 20(8):434-8. PubMed ID: 9364245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus.
    Villa-Manzano AI; Gamez-Nava JI; Salazar-Paramo M; Valera-Gonzalez IC; Garcia-Gonzalez A; Garcia-Gonzalez G; Morales-Romero J; Lopez-Olivo A; Galvan-Ramirez LM; Ruiz-Ruvalcaba R; Cardona-Muñoz EG; Gonzalez-Lopez L
    Rheumatol Int; 2006 Jun; 26(8):712-6. PubMed ID: 16231121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.